Esta Multi Usaha Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Esta Multi Usaha Tbk. trades at Rp172 (market cap 422.01B, 3.9M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Esta Multi Usaha Tbk. is far larger — about 4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| ESTA | SCPI | |
|---|---|---|
Market Cap | 422.01B | 104.4B |
Volume | 3.9M | — |
Lot | 39.02K | — |
Turnover | 691.55M | — |
Average Price | 177.25 | — |
Value | 691.55M | — |
Indicative Equilibrium Price | 172 | — |
Indicative Equilibrium Volume | 235 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Esta Multi Usaha Tbk (the “Company”) was established under the name PT Esta Asri Propertindo, based on Notarial Deed No. 34 dated September 30, 2011 of Kun Hidayat, S.H., notary in Jakarta. The Company started its commercial operations in 2012. Until 2017, the Company only did real estate leasing business activities. In 2018, the Company started its hospitality business activities.Whereas in 2019, the Company commenced vehicle rental business activities without option rights.
Read more on ESTA →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →